COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study

References

• https://lab24.ilsole24ore.com/numeri-vaccini-italia-mondo/#vaccinati-per-fasce-di-eta. [[cited Date] 2022 Feb 14].
   Google Scholar
• Barda N, Dagan N. The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines. Clin Microbiol Infect. 2021;28:SS1198–5. Epub ahead of print. PMID: 34906720; PMCID: PMC8665840.
   Web of Science ®Google Scholar
• Italian National Institute of Health (ISS)/Italian Ministry of Health. Impact of COVID-19 vaccination on the risk of SARS-CoV-2 infection and hospitalization and death in Italy (27.12.2020 - 29.08.2021). Report 4/2021. https://www.iss.it/documents/20126/0/report_on_vaccine_effectiveness_Italy+%281%29.pdf/53d71dc2-c8c5-24c1-3467-705a8587a339?t=1633529045681. [[cited Date] 2022 Feb 14].
   Google Scholar
• Fabiani M, Ramigni M, Gobbetto V, et al. Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers. Treviso province, Veneto region, Italy, 27 December 24 March Eurosurveillance. 2021:2617:2100420.
   Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control https://www.ecdc.europa.eu/en/covid-19/country-overviews [[cited Date] 2022 Feb 14].
   Google Scholar
• Russo AG, Tunesi S, Consolazio D, et al. Evaluation of the anti-COVID-19 vaccination campaign in the metropolitan area of milan (Lombardy Region, Northern Italy). Epidemiol Prev. 2021;45(6):568–579. PMID: 34791867.
   PubMed Web of Science ®Google Scholar
• Fabiani M, Riccardo F, Di Napoli A, et al. Differences in influenza vaccination coverage between adult immigrants and Italian Citizens at risk for influenza-Related Complications: a Cross-Sectional study. PLoS One. 2016;11(11):e0166517. PMID: 27832186; PMCID: PMC5104396.
   PubMed Web of Science ®Google Scholar
• Italian Ministry of Health. COVID-19 – norme, circolari e ordinanze. https://www.salute.gov.it/portale/nuovocoronavirus/archivioNormativaNuovoCoronavirus.jsp [[cited Date] 2022 Feb 14].
   Google Scholar
• Pacelli B, Zengarini N, Broccoli S, et al. Differences in mortality by immigrant status in Italy. results of the Italian network of longitudinal metropolitan studies. Eur J Epidemiol. 2016;31(7):691–701. Epub 2016 Jul 26. PMID: 27461270.
   PubMed Web of Science ®Google Scholar
• Cesaroni G, Agabiti N, Rosati R, et al. An index of socioeconomic position based on 2001 Census, Rome[Italian]. Epidemiol Prev. 2006;30(6):352–357.
   PubMedGoogle Scholar
• Istituto Nazionale di Statistica. I.Stat Tavole di mortalità. http://dati.istat.it/Index.aspx?DataSetCode=DCIS_MORTALITA1 [[cited Date] 2022 Feb 14].
   Google Scholar
• Mansournia MA, Nazemipour M, Etminan M. Causal diagrams for immortal time bias. Int J Epidemiol. 2021;50(5):1405–1409.
   PubMed Web of Science ®Google Scholar
• Renoux C, Azoulay L, Suissa S. Biases in evaluating the safety and effectiveness of drugs for the treatment of COVID-19: designing Real-World evidence studies. Am J Epidemiol. 2021;190(8):1452–1456. PMID: 33564823; PMCID: PMC7929453.
   PubMed Web of Science ®Google Scholar
• Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393–1400. Epub 2021 Sep 15. PMID: 34525275; PMCID: PMC8461568.
   PubMed Web of Science ®Google Scholar
• Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022 published online ahead of print, Feb 4;399:814–823.
   PubMed Web of Science ®Google Scholar
• Katikireddi SV, Cerqueira-Silva T, Vasileiou E, et al. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet. 2022;399(10319):25–35. Epub 2021 Dec 20. PMID: 34942103; PMCID: PMC8687670.
   PubMed Web of Science ®Google Scholar
• Liu Q, Qin C, Liu M, et al. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10(1):132. PMID: 34776011; PMCID: PMC8590867.
   PubMed Web of Science ®Google Scholar
• Barda N, Dagan N, Cohen C, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093–2100.
   PubMed Web of Science ®Google Scholar
• Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–1829. Epub 2021 May 5. Erratum in: Lancet 2021;398(10296):212. PMID: 33964222; PMCID: PMC8099315.
   PubMed Web of Science ®Google Scholar
• Istituto Superiore di Sanità. Prevalenza e distribuzione delle varianti di SARS-CoV-2 di interesse per la sanità pubblica in Italia. Rapporton. 16. del 19 gennaio 2022. [Last accessed 2022 Feb 14]. https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-19-gennaio-2022.pdf
   Google Scholar
• Fano V, Alessia A, Coviello E, et al. Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy). Vaccine. 2022 in press;40:2540–2545.
   PubMed Web of Science ®Google Scholar
• Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725–1735. Epub 2021 Apr 23. PMID: 33901423; PMCID: PMC8064668.
   PubMed Web of Science ®Google Scholar
• Fabiani M, Puopolo M, Morciano C et al. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study. BMJ. 2022;376:e069052 doi:10.1136/bmj-2021-069052.
   PubMedGoogle Scholar
• Vasileiou E, Simpson CR, Shi T, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397(10285):1646–1657. Epub 2021 Apr 23. PMID: 33901420; PMCID: PMC8064669.
   PubMed Web of Science ®Google Scholar
• Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50. Epub 2021 Mar 11. PMID: 33713824; PMCID: PMC7946541.
   PubMed Web of Science ®Google Scholar
• Saban M, Myers V, Ben-Shetrit S, et al. Socioeconomic gradient in COVID-19 vaccination: evidence from Israel. Int J Equity Health. 20218;20(1):242. PMID: 34749718; PMCID: PMC8574141.
   PubMed Web of Science ®Google Scholar
• Jain A, van Hoek AJ, Boccia D, et al. Lower vaccine uptake amongst older individuals living alone: a systematic review and meta-analysis of social determinants of vaccine uptake. Vaccine. 2017;35(18):2315–2328. Epub 2017 Mar 27. PMID: 28343775.
   PubMed Web of Science ®Google Scholar
• Yanguas J, Pinazo-Henandis S, Tarazona-Santabalbina FJ. The complexity of loneliness. Acta Biomed. 2018;89(2):302–314. PMID: 29957768; PMCID: PMC6179015.
   PubMedGoogle Scholar
• Fano V, Moretti I, Caprioli R, et al. Condizioni cliniche e contesto sociale: capacità predittiva di un indicatore di fragilità sulla mortalità intra-ospedaliera a 18 mesi. Acta of the 54° Congresso Nazionale SITI - La Sanità Pubblica nel Post-Covid, 03–06 novembre 2021, Lecce 3-6 novembre 2021. [Italian]
   Google Scholar
• Manzoli L, Villari P, Pirone M, et al. Marital status and mortality in the elderly: a systematic review and meta-analysis. Soc Sci Med. 2007;64(1):77–94. Epub 2006 Sep 29. PMID: 17011690.
   PubMed Web of Science ®Google Scholar
• Fabiani M, Fano V, Spadea T, et al. Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: a multi-centre retrospective cohort study. Vaccine. 2019;37(16):2179–2187.
   PubMed Web of Science ®Google Scholar
• Spadea T, Fano V, Piovesan C, et al. Early childhood vaccination coverage and timeliness by macro-area of origin in children born to foreign women residing in Italy: a multicentre retrospective cohort study. Public Health. 2021;196:138–145.
   PubMedGoogle Scholar
• Fabiani M, Mateo-Urdiales A, Andrianou X, et al. Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system. Eur J Public Health. 2021;31(1):37–44. PMID: 33416859; PMCID: PMC7851886.
   PubMed Web of Science ®Google Scholar
• Halloran ME. Discussion on “Estimating vaccine efficacy over time after a randomized study is unblinded. by Anastasios A. Tsiatis, Davidian M editors. published online ahead of 2021 Aug 22 Biometrics. 2021. 10.1111/biom.13540
   Web of Science ®Google Scholar
• Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 2021 Jul 22. Addendum to evaluation of COVID-19 vaccine effectiveness. WHO, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-variants-2021.1 [[cited Date] 2022 Feb 14].
   Google Scholar